An external evaluation of a peer-run outreach-based syringe exchange in Vancouver, Canada

References 

1. Broadhead RS, Heckathorn DD, Grund J-PC, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS: Preliminary results of a peer-driven intervention. Journal of Drug Issues. 1995;25(3):531–564
2. Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ, et al. Harnessing peer networks as an instrument for AIDS prevention: Results from a peer-driven intervention. Public Health Reports. 1998;113(Suppl. 1):42–57
3. Corneil TA, Kuyper LM, Shoveller J, Hogg RS, Li K, Spittal PM, et al. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health & Place. 2006;12(1):79–85
   • MEDLINE
   • CrossRef
4. Csete J, Cohen J. Abusing the user: Police misconduct, harm reduction and HIV/AIDS in Vancouver. New York: Human Rights Watch; 2003;
5. DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T. Public injecting among a cohort of injecting drug users in Vancouver, Canada. Journal of Epidemiology and Community Health. 2009;63(1):81–86
6. Eby D. The political power of police and crackdowns: Vancouver's example. International Journal of Drug Policy. 2006;17(2):96–100
7. Farrell M, Gowing L, Marsden J, Ling W, Ali R. Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy. 2005;16(Suppl. 1):67–75
8. Friedman SR, de Jong W, Rossi D, Touze G, Rockwell R, Des Jarlais DC, et al. Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. International Journal of Drug Policy. 2007;18(2):107–117
9. Grund JP, Blanken P, Adriaans NF, Kaplan CD, Barendregt C, Meeuwsen M. Reaching the unreached: Targeting hidden IDU populations with clean needles via known user groups. Journal of Psychoactive Drugs. 1992;24(1):41–47
   • MEDLINE
   • CrossRef
10. Kerr T, Small W, Peeace W, Douglas D, Pierre A, Wood E. Harm reduction by a “user-run” organization: A case study of the Vancouver Area Network of Drug Users (VANDU). International Journal of Drug Policy. 2006;17(2):61–69
11. Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. The Lancet. 2005;366(9482):316–318
12. Latkin CA. Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Reports. 1998;113(Suppl. 1):151–159
13. Lee JH, Herzog TA, Meade CD, Webb MS, Brandon TH. The use of GEE for analyzing longitudinal binomial data: A primer using data from a tobacco intervention. Addictive Behaviors. 2007;32(1):187–193
    • MEDLINE
    • CrossRef
14. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. The Lancet. 2008;372(9651):1733–1745
15. Needle RH, Burrows D, Friedman SR, Dorabjee J, TouzÈ G, Badrieva L, et al. Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. International Journal of Drug Policy. 2005;16(Suppl. 1):45–57
16. Small W, Kerr T, Charette J, Schechter MT, Spittal PM. Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation. International Journal of Drug Policy. 2006;17(2):85–95
17. Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PG, Rekart M, et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction. 1997;92(10):1339–1347
    • MEDLINE
    • CrossRef
18. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–65
    • MEDLINE
    • CrossRef
19. The Global HIV Prevention Working Group. (2007). Bringing HIV prevention to scale: An urgent global priority. Retrieved November 12, 2009, from http://www.globalhivprevention.org/pdfs/PWG-HIV_prevention_report_FINAL.pdf.
20. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887–893
    • MEDLINE
    • CrossRef
21. UNAIDS . Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2008;
22. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use & Misuse. 2006;41(6–7):777–813
23. Wood E, Kerr T, Small W, Jones J, Schechter MT, Tyndall MW. The impact of a police presence on access to needle exchange programs. Journal of Acquired Immune Deficiency Syndromes. 2003;34(1):116–118
24. Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O'Shaughnessy MV, et al. An external evaluation of a peer-run “unsanctioned” syringe exchange program. Journal of Urban Health. 2003;80(3):455–464
25. Wood E, Spittal PM, Small W, Kerr T, Li K, Hogg RS, et al. Displacement of Canada's largest public illicit drug market in response to a police crackdown. Canadian Medical Association Journal. 2004;170(10):1551–1556
26. Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, et al. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002;16(6):941–943
    • MEDLINE
    • CrossRef
27. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. Canadian Medical Association Journal. 2001;165(4):405–410